Pyxis Oncology, Inc. (PYXS) Reports In-Line Q1 EPS

Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q1 EPS of ($0.37), in-line with the analyst estimate of ($0.37).

For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.

You May Also Be Interested In

• Jefferies Downgrades Klepierre SA (LI:FP) (KLPEF) to Hold
• Jefferies Downgrades Severn Trent Plc. (SVT:LN) (SVTRF) to Hold
• Barclays Upgrades Thales SA (HO:FP) (THLEF) to Equalweight